nach oben

Erschienen in:

01.06.2021 | News item

Irbesartan, losartan, valsartan lots recalled in Canada: azido impurity

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Health Canada is advising that multiple lots of irbesartan, losartan and valsartan from several drug companies are being recalled in Canada due to unacceptable levels of an azido impurity which is considered to be a mutagen and may increase the risk of cancer. …

Health Canada. Multiple lots of irbesartan, losartan and valsartan drugs recalled due to azido impurity. Internet Document : 30 May 2021. Available from: URL: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75715a-eng.php

Titel: Irbesartan, losartan, valsartan lots recalled in Canada: azido impurity
Publikationsdatum: 01.06.2021
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-97098-8

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Dapsone/isotretinoin

Alectinib

Benzocaine

Multiple drugs

Heparin

Nivolumab/prednisolone/sunitinib